Clinical Trial Update: A Pilot Study to Evaluate the Systemic Effect of Oral Supplementation With AM3 in Patients With Metabolic Syndrome. [NA]

View source ↗

Summary

A pilot study is evaluating the systemic effects of oral AM3 supplementation in individuals with metabolic syndrome; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• AM3

Snippet

Sponsor: Industrial Farmacéutica Cantabria, S.A. | Conditions: Metabolic Syndrome | NA | Status: RECRUITING